Public, NASDAQ:BPAX
NASDAQ Global Market
Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals ...
Date: Mon, 06 Feb 2012 14:05:49 GMT
Tags:
Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals ...
MarketWatch (press release) - 2 hours ago
MarketWatch (press release) - 2 hours ago
SAN DIEGO, Feb 06, 2012 (BUSINESS WIRE) -- Shareholder rights firm Robbins Umeda LLP, announces that the firm commenced a class action lawsuit on February 3, 2012 in the US District Court for the Northern District of Illinois, Eastern Division, ...
Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc.
Date: Mon, 06 Feb 2012 14:04:00 GMT
Tags:
Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc.
Reuters Key Development - 2 hours ago
Reuters Key Development - 2 hours ago
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Under Investor Investigation over ...
Date: Wed, 01 Feb 2012 15:40:56 GMT
Tags:
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Under Investor Investigation over ...
SBWire (press release) - Feb 1, 2012
SBWire (press release) - Feb 1, 2012
An investigation for shareholders of BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) over possible securities laws violations in connection with LibiGel efficacy trial results was announced and NASDAQ:BPAX) stockholders should contact the Shareholders ...
Biotech stocks News; BioSante Pharmaceuticals (NASDAQ: BPAX) Provides ...
Date: Tue, 31 Jan 2012 14:45:46 GMT
Tags:
Biotech stocks News; BioSante Pharmaceuticals (NASDAQ: BPAX) Provides ...
InvestorIdeas.com (press release) (subscription) - Jan 31, 2012
InvestorIdeas.com (press release) (subscription) - Jan 31, 2012
LINCOLNSHIRE, Ill. - January 31, 2012 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced a corporate update.
BioSante Pharmaceuticals Provides Corporate Update - EON: Enhanced Online News (press release)Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies
Date: Tue, 31 Jan 2012 13:23:21 GMT
Tags:
Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies
Marketwire (press release) - Jan 31, 2012
Marketwire (press release) - Jan 31, 2012
NEW YORK, NY--(Marketwire - Jan 31, 2012) - Biotechnology stocks have been on a tear this month, gaining an impressive 11 percent.
Robbins Umeda LLP Announces Class Action Suit Against BioSante Pharmaceuticals, Inc.
Date: Mon, 06 Feb 2012 14:05:00 GMT
Tags:
[Business Wire] - Shareholder rights firm Robbins Umeda LLP, announces that the firm commenced a class action lawsuit on February 3, 2012 in the U.S. District Court for the Northern District of Illinois, Eastern Division, on behalf of all persons or entities who purchased or otherwise acquired the securities of BioSante Pharmaceuticals, Inc.
Nasdaq ‘Threshold’ Securities for Feb. 3
Date: Mon, 06 Feb 2012 00:58:20 GMT
Tags:
AstraZeneca Axes 7,300 Jobs, 12% Of Workforce
Date: Sun, 05 Feb 2012 17:20:58 GMT
Tags:
BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o
Date: Fri, 03 Feb 2012 22:11:21 GMT
Tags:
What's Going on With These Biotech Stocks?
Date: Fri, 03 Feb 2012 18:38:58 GMT
Tags: